PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of archdischArchives of Disease in ChildhoodVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Arch Dis Child. 1994 October; 71(4): 349–352.
PMCID: PMC1030018

Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Abstract

Five children with cystic fibrosis complicated by hepatic cirrhosis received liver grafts. They all had portal hypertension with varices and three had variceal bleeding; respiratory function was only moderately impaired, but four were colonised with pseudomonas and one with aspergillus. Liver transplantation was well tolerated and there was no increase in respiratory or other early postoperative complications. Four of the children were fully well from 14 to 35 months after transplantation; the most recently transplanted had problems from a biliary stricture. In spite of the need for immunosuppression there was no increase in infection and respiratory function improved or remained stable. Once the children were stabilised after transplantation their nutrition and general health were greatly improved.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (665K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child. 1991 Jun;66(6):698–701. [PMC free article] [PubMed]
  • Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. Arch Dis Child. 1993 May;68(5):653–657. [PMC free article] [PubMed]
  • Tanner MS. Liver and biliary problems in cystic fibrosis. J R Soc Med. 1992;85 (Suppl 19):20–24. [PubMed]
  • Cotting J, Lentze MJ, Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut. 1990 Aug;31(8):918–921. [PMC free article] [PubMed]
  • Stern RC, Stevens DP, Boat TF, Doershuk CF, Izant RJ, Jr, Matthews LW. Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic hunting. Gastroenterology. 1976 May;70(5 PT1):645–649. [PubMed]
  • Nagel RA, Westaby D, Javaid A, Kavani J, Meire HB, Lombard MG, Wise A, Williams R, Hodson ME. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet. 1989 Dec 16;2(8677):1422–1425. [PubMed]
  • Schwarz HP, Kraemer R, Thurnheer U, Rossi E. Liver involvement in cystic fibrosis. A report of 9 cases. Helv Paediatr Acta. 1978 Nov;33(4-5):351–364. [PubMed]
  • Tyson KR, Schuster SR, Shwachman H. Portal hypertension in cystic fibrosis. J Pediatr Surg. 1968 Apr;3(2):271–277. [PubMed]
  • Mieles LA, Orenstein D, Teperman L, Podesta L, Koneru B, Starzl TE. Liver transplantation in cystic fibrosis. Lancet. 1989 May 13;1(8646):1073–1073. [PubMed]
  • Greally P, Hussein MJ, Cook AJ, Sampson AP, Piper PJ, Price JF. Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child. 1993 Mar;68(3):389–392. [PMC free article] [PubMed]
  • Dodge JA, Morrison G. Diabetes mellitus in cystic fibrosis: a review. J R Soc Med. 1992;85 (Suppl 19):25–28. [PubMed]
  • TANNER JM, WHITEHOUSE RH. Standards for subcutaneous fat in British children. Percentiles for thickness of skinfolds over triceps and below scapula. Br Med J. 1962 Feb 17;1(5276):446–450. [PMC free article] [PubMed]
  • Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981 Nov;34(11):2540–2545. [PubMed]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group